Advertisement
Grab your lab coat. Let's get started
Welcome!
Welcome!
Create an account below to get 6 C&EN articles per month, receive newsletters and more - all free.
It seems this is your first time logging in online. Please enter the following information to continue.
As an ACS member you automatically get access to this site. All we need is few more details to create your reading experience.
Not you? Sign in with a different account.
Not you? Sign in with a different account.
ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
Specialty Chemicals
Arkema and Clariant slim down
by Matt Blois
November 3, 2022
| A version of this story appeared in
Volume 100, Issue 39
The specialty chemical makers Arkema and Clariant are each divesting a business. France’s Arkema is selling its phosphorus derivatives business Febex, which posted $30 million in sales last year, to Belgium-based Prayon. Arkema’s phosphoric acid, sodium hypophosphite, and derivatives are used primarily in electronics and pharmaceuticals. Meanwhile, the Swiss chemical company Clariant will sell its North American oil exploration chemical business, which had revenue of $113 million last year, to the Indian chemical company Dorf Ketal.
Chemical & Engineering News
ISSN 0009-2347
Copyright © 2024 American Chemical Society
You might also like...
The power is now in your (nitrile gloved) hands
Sign up for a free account to get more articles. Or choose the ACS option that’s right for you.
Already have an ACS ID? Log in
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on Twitter